Assessment of risk factors in men of military age with arterial hypertension

Cardiovascular risk factors studied in people aged 18–26 years with grade 1–2 arterial hypertension. Obesity, hyperuricemia and smoking identified as the leading causes. A significant relationship between hyperuricemia and impaired fat metabolism and the abuse of drinks containing fructose revealed. Assessment of structural and functional parameters of the heart did not reveal signs of pathological remodeling. The data obtained indicate the need for routine assessment of uric acid levels in young patients with hypertension and prehypertension. Correction of eating behavior in young people may potentially be more significant in reducing blood pressure and preventing cardiac remodeling compared to patients in older age groups.

1. Aleksandrov, A. A. Klinicheskie rekomendacii Diagnostika, lechenie i profilaktika arterial’noj gipertenzii u detej i podrostkov / A. A. Aleksandrov, O. A. Kislyak, I. V. Leont’eva // Sistemnye gipertenzii. – 2020. – T. 17, № 2. – S. 7–35.

2. Aleksandrov, A. A. Profilaktika serdechno-sosudistyh zabolevanij v detskom i podrostkovom vozraste / A. A. Aleksandrov, M. G. Bubnova, O. A. Kislyak // Ateroskleroz. – 2013. – T. 1, № 9. – S. 99–140.

3. Georginova, O. A. Modificiruemye faktory pitaniya pri giperurikemii i podagre / O. A. Georginova // Al’manah klinicheskoj mediciny. – 2022. – № 4. – S. 264–273.

4. Dashieva, E. B. Arterial’naya gipertenziya u lic molodogo vozrasta: osnovnye faktory riska razvitiya / E. B. Dashieva // Sibirskoe medicinskoe obozrenie. – 2020. – № 4. – S. 12–19.

5. Kislyak, O. A. Evrazijskie klinicheskie rekomendacii po profilaktike serdechno-sosudistyh zabolevanij v detskom i podrostkovom vozraste (2023). / O. A. Kislyak, I. V. Leont’eva, A. V. Starodubova // Evrazijskij kardiologicheskij zhurnal. – 2023. – № 3. – S. 6–35.

6. Klinicheskie rekomendacii Associacii detskih kardiologov Rossii. Arterial’naya gipertenziya u detej i podrostkov, 2021 g.

7. Kobalava, ZH. D. Arterial’naya gipertenziya u vzroslyh. Klinicheskie rekomendacii 2024 / ZH. D. Kobalava, A. O. Konradi, S. V. Nedogoda // Rossijskij kardiologicheskij zhurnal. – 2024. – T. 29, № 9. – S. 230–329.

8. Kovalyova, I. V. Mnogogrannaya giperurikemiya: sovremennye podhody k diagnostike nachinaya s bessimptomnoj stadii i vyboru strategii lecheniya / I. V. Kovalyova // Lechashchij Vrach. – 2021. – T. 6, № 24. – S. 64–71.

9. Muromceva, G. A. Rasprostranennost’ faktorov riska neinfekcionnyh zabolevanij v rossijskoj populyacii v 2012–2013 gg. Rezul’taty issledovaniya ESSE-RF / G. A. Muromceva, A. V. Koncevaya, V. V. Konstantinov // Kardiovaskulyarnaya terapiya i profilaktika. – 2014. – T. 13, № 6. – S. 4–11.

10. Nechesova, T. A. Remodelirovanie levogo zheludochka: patogenez i metody ocenki / T. A. Nechesova // Medicinskie novosti. – 2008. – № 64. – S. 7–13.

11. Sachek, M. M. Vyyavlenie rasprostranennosti faktorov riska neinfekcionnyh zabolevanij v Respublike Belarus’: Steps-issledovanie [Elektronnyj resurs] / M. M. Sachek, I. I. Novik, V. M. Pisarik // Sovremennye aspekty zdorov’esberezheniya: sb. materialov yubil. nauch.-prakt. konf. s mezhdunar. uchastiem, posvyashch. 55-letiyu med.-prof. fak-ta UO BGMU, Minsk, 23–24 maya 2019 g. / pod red. A. V. Sikorskogo, A. V. Gindyuka, T. S. Borisovoj. – Minsk, 2019. – S. 277–281. – 1 elektron. opt. disk (CD-ROM).

12. Turchina, ZH. E. Arterial’naya gipertenziya u podrostkov: analiz faktorov riska, rol’ shkol’noj medicinskoj sestry v profilaktike / ZH. E. Turchina, N. V. Fukalova, YU. N. SHageeva // Medicinskaya sestra. – 2021. – T. 1, № 23. – S. 14–18.

13. SHal’nova, S. A. Arterial’naya gipertoniya sredi lic 25–64 let: rasprostranennost’, osvedomlennost’, lechenie i kontrol’. Po materialam issledovaniya ESSE / S. A. SHal’nova, A. D. Deev, G. V. Artamonova // Kardiovaskulyarnaya terapiya i profilaktika. – 2014. – № 4. – S. 4–14.

14. Borghi, C. Uric Acid and Hypertension: a Review of Evidence and Future Perspectives for the Management of Cardiovascular Risk / C. Borghi, D. Agnoletti, A. F. G. Cicero // Hypertension Research. – 2022. – № 9. – P. 1927–1936.

15. Chen-Xu, M. Contemporary Prevalence of Gout and Hyperuricemia in the United States and Decadal Trends / M. Chen-Xu, C. Yokose, S. K. Rai // American College of Rheumatology. – 2019. – № 6. – P. 991–999.

16. Gill, D. Urate, blood pressure, and cardiovascular disease: evidence from mendelian randomization and meta-analysis of clinical trials / D. Gill, A. C. Cameron, S. Burgess // Hypertension Research. – 2021. – № 77. – P. 383–392.

17. Keenan, R. T. Etiology and Pathogenesis of Hyperuricemia and Gout / R. T. Keenan, S. Krasnokutsky, M. H. Pilinger // American Journal of Medicine. – 2017. – № 46. – P. 754–758.

18. Lurbe, E. European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents. / E. Lurbe, E. Aganiti-Roseic, J. K. Cruickshankd // J Hypertens. – 2016. – Vol. 34, № 10. – P. 887–920.

19. Ubhadiya, T. J. Exploring the effects of elevated serum uric acid levels on hypertension: a scoping review of hyperuricemia. / T. J. Ubhadiya, N. Dubey, M. H. Sojitra // Cureus. – 2023. – Vol. 15, № 4. – P. 33–61.

20. Wang, Z. The relationship between hyperuricemia and hypertension: a short review of current evidence / Z. Wang, G. Yao, B. Yan // Metabolism and Target Organ Damage. – 2023. – № 4. – P. 3–4.